Actinium Pharmaceuticals (Delaware) (ATNM) vs Rockwell Medical (RMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Actinium Pharmaceuticals (Delaware) (ATNM) has outperformed Rockwell Medical (RMTI) over the past year, losing 26.7% versus a loss of 34.8%. Over five years, ATNM leads with a -86.3% price change compared with -88.0% for RMTI. Actinium Pharmaceuticals (Delaware) is the larger company by market cap ($34.6 million vs $31.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATNM | RMTI |
|---|---|---|
| Share price | $1.10 | $7.89 |
| Market cap | $34.59M | $31.80M |
| 1-day change | +1.85% | -1.62% |
| YTD return | -19.12% | -4.94% |
| 1-year return | -26.67% | -34.79% |
| 5-year return | -86.32% | -88.05% |
| P/E ratio (TTM) | 3.06 | — |
| Forward P/E | — | 112.71 |
| EPS (TTM) | $0.36 | $-1.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.74 | $12.90 |
| 52-week low | $0.735 | $4.89 |
| Distance from 52-week high | -36.78% | -38.84% |
| Analyst consensus | none | none |
| Avg. price target upside | +227.27% | +153.49% |
| Average volume | 139.78K | 26.44K |
| Shares outstanding | 31.44M | 4.03M |
| Employees | 27 | 157 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Actinium Pharmaceuticals (Delaware)
ATNM stock →Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 27 employees
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees
ATNM vs RMTI FAQ
Which is bigger, Actinium Pharmaceuticals (Delaware) or Rockwell Medical?
Actinium Pharmaceuticals (Delaware) (ATNM) is larger, with a market capitalization of $34.59M compared with $31.80M for Rockwell Medical (RMTI).
Which stock has performed better over the past year, ATNM or RMTI?
ATNM returned -26.67% over the past 12 months, compared with -34.79% for RMTI (price return, excluding dividends). Past performance does not predict future results.
Are Actinium Pharmaceuticals (Delaware) and Rockwell Medical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.